People channel feed – Endpoints News

People channel feed

Small is big: Pharma’s R&D brain drain continues as GSK’s Chris Carpenter jumps to upstart Rubius

8 years ago

Pfizer spins off drug orphans into a PhIII-ready startup backed by Bain to the tune of $103M

8 years ago

Chris Garabedian's Xontogeny shepherds its first biotech through a $10M startup round

8 years ago

After settling with the SEC, biotech VC Steven Burrill now faces up to 30 years for fraud, tax evasion charges

8 years ago

Tech maven Travis May takes the helm of Roivant's data mining startup

8 years ago

From big biopharma to biotech CEO, John Houston’s R&D journey highlights a fast-changing world

8 years ago

OncoMed chief Paul Hastings goes on medical leave

8 years ago

Ex-GSK CEO, R&D chief Andrew Witty and Moncef Slaoui are jumping into the biotech VC game

8 years ago

Harvard biotech wiz Greg Verdine grabs a $55M A round to build a groundbreaking biotech

8 years ago

Want to start a fight? Step one: Offer up an estimate for what it costs to develop a new drug

8 years ago

Convicted felon Martin Shkreli has finally talked his way behind bars

8 years ago

Mylan attacks Allergan over its Mohawk-allied patent strategy — but the CEO is sticking to his guns

8 years ago

Troubled Teva poaches Lundbeck CEO Schultz with an offer he couldn't refuse, including $20M in cash

8 years ago

Prosecutors want Shkreli thrown in jail now after Facebook threat

8 years ago

Replimune adds a $55M round and some expert help as it pursues next-gen oncolytics R&D

8 years ago

Novartis follows up on big CAR-T win by naming Vas Narasimhan as its new CEO

8 years ago

Top FDA trial expert Richard Moscicki jumps to a senior post at PhRMA

8 years ago

Meet Bertrand Bodson, Novartis’ new global digital strategy maestro for all things Big Pharma

8 years ago

Key figure in notorious biopharma insider case loses an appeal — broadening scope for future cases

8 years ago

Here’s why 23-year-old Laura Deming is betting $22M on anti-aging R&D

8 years ago

Jurors: In the end, Martin Shkreli was done in by his own inflated ego

8 years ago

Price gouging on drugs? Shkreli's jury selection process reveals some deep public anger

8 years ago

Top UCSF scientist Shaun Coughlin joins migration to Big Pharma, leaping to Novartis

8 years ago

Gushing red ink, biotech billionaire Soon-Shiong slashes staff at NantHealth by 300, sells assets

8 years ago

First page Previous page 92 93 949596 97 98 Next page Last page